Ascendis veteran leaves chair role at Swedish biotech firm

Michael Wolff Jensen, former long-standing chair of the board of directors at Ascendis Pharma where he is also employed as chief legal officer, has resigned from his chair position at Swedish firm Vicore Pharma ”due to personal reasons.”

Photo: Kevin Grønnemann

After around two years on the board of directors at Swedish biotech firm Vicore Pharma, Michael Wolff Jensen has decided to step down from his chair position, the company has announced in a press release.

According to the statement, Wolff Jensen’s resignation from the board, where he has served since 2020, is ”due to personal reasons.”

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

CHMP to remove 100 generic medicines from market

Due to fraudulent clinical trials from a contract research organization, the EMA’s expert committee, the CHMP, is now suspending marketing approval authorizations for around 100 generic drugs on the market.

Further reading

Related articles

Latest news

See all jobs